Original Query: ALL
Previous Study | Return to List | Next Study

Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) (ACE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00989261
Recruitment Status : Completed
First Posted : October 5, 2009
Last Update Posted : January 5, 2018
Information provided by (Responsible Party):
Daiichi Sankyo, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2012
  Study Completion Date : September 2012
  Certification/Extension First Submitted : September 30, 2016